NMD Pharma raises $47M in series A investment round from INKEF and existing investors, to advance treatments of neuromuscular disorders

Biotech Health services Pharma

Investments

23 March 2018

NMD Pharma (company)

Biotech Health services Pharma

Total investments received (USD): 169.32m

Round value (USD): 47m

Round investors: Inkef Capital Lundbeckfond Ventures Novo Seeds Roche Venture Fund

Industry: Biotech Health services Pharma

Competitive Intelligence Software Services

Investments 28 August 2018

Gaming Industry Sports Industry

MA 29 June 2018

Industry agnostic Software Services

Secondary 14 June 2018

Competitive Intelligence

Investments 27 February 2018

Ecommerce Food Industry Mobile Retail

Investments 14 February 2018